1. Home
  2. CVAC vs GSM Comparison

CVAC vs GSM Comparison

Compare CVAC & GSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • GSM
  • Stock Information
  • Founded
  • CVAC 2000
  • GSM 2015
  • Country
  • CVAC Germany
  • GSM United Kingdom
  • Employees
  • CVAC N/A
  • GSM N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • GSM Metal Mining
  • Sector
  • CVAC Health Care
  • GSM Basic Materials
  • Exchange
  • CVAC Nasdaq
  • GSM Nasdaq
  • Market Cap
  • CVAC 818.8M
  • GSM 739.5M
  • IPO Year
  • CVAC 2020
  • GSM N/A
  • Fundamental
  • Price
  • CVAC $3.30
  • GSM $3.48
  • Analyst Decision
  • CVAC Hold
  • GSM
  • Analyst Count
  • CVAC 3
  • GSM 0
  • Target Price
  • CVAC $10.00
  • GSM N/A
  • AVG Volume (30 Days)
  • CVAC 617.5K
  • GSM 778.8K
  • Earning Date
  • CVAC 11-12-2024
  • GSM 02-19-2025
  • Dividend Yield
  • CVAC N/A
  • GSM 1.49%
  • EPS Growth
  • CVAC N/A
  • GSM N/A
  • EPS
  • CVAC N/A
  • GSM 0.03
  • Revenue
  • CVAC $70,565,734.00
  • GSM $1,643,939,000.00
  • Revenue This Year
  • CVAC $742.57
  • GSM $2.06
  • Revenue Next Year
  • CVAC N/A
  • GSM $6.65
  • P/E Ratio
  • CVAC N/A
  • GSM $130.29
  • Revenue Growth
  • CVAC 75.11
  • GSM N/A
  • 52 Week Low
  • CVAC $2.22
  • GSM $3.45
  • 52 Week High
  • CVAC $5.28
  • GSM $6.19
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 39.12
  • GSM 28.73
  • Support Level
  • CVAC $3.53
  • GSM $3.80
  • Resistance Level
  • CVAC $3.72
  • GSM $3.97
  • Average True Range (ATR)
  • CVAC 0.18
  • GSM 0.16
  • MACD
  • CVAC -0.06
  • GSM -0.04
  • Stochastic Oscillator
  • CVAC 10.96
  • GSM 3.85

About CVAC CureVac N.V.

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel and ductile iron foundry industries. The company's business segments include North America - Silicon; Europe - Manganese; Europe - Silicon; South Africa - Silicon and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

Share on Social Networks: